| AP-1 | Activator protein 1 |
| APC | Activated protein C |
| APS | Antiphospholipid Syndrome |
| ATIII | Antithrombin III |
| AQP | Aquaporin channel |
| CAM | Cell adhesion molecule |
| CCR2 | C-C chemokine receptor type 2 |
| CGD | X-linked chronic granulomatous disease |
| COX | Cyclooxygenase |
| CVD | Cardiovascular disease |
| CAM | Cell adhesion molecule |
| CTEPH | Chronic thromboembolic pulmonary hypertension |
| DVT | Deep vein thrombosis |
| ECM | Extracellular matrix |
| EVAL | Ethylene-vinyl-alcohol |
| fMLP | N-formyl-met-leu-phe |
| FX | Factor X |
| FXI | Factor XI |
| GPVI | Glycoprotein VI |
| GPX | Glutathione peroxidase |
| Hb | Hemoglobin |
| HCQ | Hydroxychloroquine |
| HIF | Hypoxia-inducible factor |
| HO | Heme oxygenase |
| HUVEC | Human umbilical vein endothelial cell |
| IgE | Immunoglobulin E |
| IL-8 | Interleukin-8 |
| IVC | Inferior vena cava |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| MC | Mast cell |
| MCP-1 | Monocyte chemotactic protein 1 |
| MMP | Matrix metalloproteinase |
| MPO | Myeloperoxidase |
| mTORC1 | Mammalian target of rapamycin complex 1 |
| MyD88 | Myeloid differentiation primary response 88 |
| NAC | N-acetylcysteine |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NLRP3 | NLR family pyrin domain containing 3 |
| NO | Nitric oxide |
| NOX | Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| NE | Neutrophil elastase |
| NET | Neutrophil extracellular trap |
| Orai1 | Calcium release-activated calcium channel protein 1 |
| Ox-LDL | Oxidized low-density lipoprotein |
| PA | Pulmonary artery |
| PAD4 | Protein-arginine deiminase type-4 |
| PAI | Plasminogen activator inhibitor |
| PE | Pulmonary embolism |
| PECAM-1 | Platelet endothelial cell adhesion molecule 1 |
| PMA | Phorbol myristate acetate |
| PSGL-1 | P-selectin glycoprotein ligand-1 |
| IVC | Inferior vena cava |
| ROS | Reactive oxygen species |
| SOCE | Store-operated calcium entry |
| STIM1 | Stromal interaction molecule 1 |
| TF | Tissue factor |
| TFPI | Tissue factor pathway inhibitor |
| TGF-β | Transforming growth factor beta |
| TIMP | Tissue inhibitor of metalloproteinases |
| TLR | Toll-like receptor |
| TM | Thrombomodulin |
| TNF-α | Tumor necrosis factor alpha |
| tPA | Tissue-type plasminogen activator |
| TRPC6 | Transient receptor potential channel 6 |
| TRX | Thioredoxin |
| uPA | Urokinase-type plasminogen activator |
| VEGF | Vascular endothelial growth factor |
| VSMC | Vascular smooth muscle cells |
| VTE | Venous thromboembolism |
| ZPI | Protein Z-dependent protease inhibitor |